Study of M5049 in DM and PM Participants (NEPTUNIA)

NCT05650567 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

40

Enrollment

INDUSTRY

Sponsor class

Stopped Based on interim analyses for futility

Conditions

Dermatomyositis
Polymyositis

Interventions

DRUG: M5049 high dose
DRUG: Placebo

Sponsor

EMD Serono Research & Development Institute, Inc.

Collaborators

[object Object]